Miki Aoi

Ichinomiya Municipal City Hospital

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Trends

Author Order

Document Type

Co-Authors

Kunio Kitamura

National Center of Neurology and Psychiatry

Hitomi Teramachi

Gifu Pharmaceutical University

Hiroaki Sakurada

Ichinomiya Municipal City Hospital

Takahiro Nishiyama

Ichinomiya Municipal City Hospital

Yuriko Sugimura

Yumiko Oshima

Ichinomiya Municipal City Hospital

Masaaki Yuge

Ichinomiya Municipal City Hospital

Tomoya Tachi

Gifu Pharmaceutical University

Akane Ryuge

Ichinomiya Municipal City Hospital

Kazuyuki Naito

Hokkaido hospital

Cooperative Institutions

Ichinomiya Municipal City Hospital

Nagoya University

Gifu Pharmaceutical University

Toyota Kosei Hospital

Gifu Municipal Hospital

Nagoya City University Hospital

Nagoya University Hospital

Higashi Nagoya National Hospital

Osaka Ohtani University

Senshu University

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Field

An analysis of 30-day mortality after the last cycle of immune checkpoint inhibitors treatment

Annals of Oncology (2019)

Akane Ryuge Yumiko Oshima Takahiro Nishiyama Miki Aoi Kunio Kitamura

Immune checkpoint

10.1093/annonc/mdz338.062

Cite

Citations (0)

[A Case of a Multidisciplinary Team Approach to Serious Hand-Foot Syndrome Induced by High-Dose Cytarabine Therapy].

PubMed (2016)

Hiroaki Sakurada Miki Aoi Masaaki Yuge Yuriko Sugimura Kunio Kitamura

A 40's year-old female patient with acute myeloblastic leukemia received high-dose cytarabine(HD-Ara-C)as her third induction therapy. Because the pharmacist in charge noticed on a prior interview that she had experienced a mild skin eruption similar to hand-foot syndrome(HFS)in the previous round oftherapy(idarubicin and cytarabine), heparinoid lotion and hypoallergenic soap were used to prevent HFS. However, HFS occurred on day 3, and further developed on day 6 to grade 3 with painful erythema, swelling, and paresthesia affecting the entire surface of both hands. We cared for her with moisturization, lifestyle guidance, rotation of steroid ointment, and occlusive dressing techniques according to a multidisciplinary team approach composed ofa hematologist, dermatologist, pharmacist, and nurse. Her symptoms resolved on day 40.

Hematologist

Erythema

Lotion

Acute myeloblastic leukemia

Source

Cite

Citations (1)